Non-Coding RNAs in Cancer Diagnosis and Therapy: Focus on Lung Cancer
Over the last several decades, clinical evaluation and treatment of lung cancers have largely improved with the classification of genetic drivers of the disease, such as EGFR, ALK, and ROS1. There are numerous regulatory factors that exert cellular control over key oncogenic pathways involved in lun...
Main Authors: | Patricia Le, Giulia Romano, Patrick Nana-Sinkam, Mario Acunzo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/6/1372 |
Similar Items
-
microRNAs as Novel Therapeutics in Cancer
by: Giulia Romano, et al.
Published: (2021-03-01) -
Non-Coding RNA Editing in Cancer Pathogenesis
by: Giulia Romano, et al.
Published: (2020-07-01) -
Recent advances in the management of non-small cell lung cancer [version 1; referees: 2 approved]
by: Samira Shojaee, et al.
Published: (2017-12-01) -
MiR-124a Regulates Extracellular Vesicle Release by Targeting GTPase Rabs in Lung Cancer
by: Giulia Romano, et al.
Published: (2020-08-01) -
Urinary Biomarkers for Early Diagnosis of Lung Cancer
by: Roberto Gasparri, et al.
Published: (2021-04-01)